• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

circ_001678/miRNA-326/ZEB1 轴通过调控 PD-1/PD-L1 通路对非小细胞肺癌的免疫调节作用。

Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway.

机构信息

Department of Respiratory, The First Hospital of Qinhuangdao, Qinhuangdao 066000, P.R. China.

Graduate School of Zunyi Medical University, Zunyi 563006, P.R. China.

出版信息

Hum Mol Genet. 2022 Nov 28;31(23):4094-4106. doi: 10.1093/hmg/ddac155.

DOI:10.1093/hmg/ddac155
PMID:35848890
Abstract

High-throughput circular RNA (circRNA) sequencing identified circRNA_001678 (circ_001678) as an upregulated circRNA in non-small cell lung cancer (NSCLC) tissues. Hence, the current study sought to investigate the function and the underlying mechanism of circRNA_001678 in immune escape of NSCLC. Briefly, commercially purchased NSCLC cell lines were adopted for in vitro experiment to evaluate the effects of circ_001678 over-expression or knockdown on cell biological functions, including proliferation, migration and invasive abilities. In addition, the effects of circ_001678 on the in vivo tumorigenicity ability were evaluated for verification. Accordingly, we uncovered that circ_001678 over-expression augmented NSCLC progression in vitro and enhanced tumorigenicity ability in vivo. The interaction between circ_001678 and miR-326 predicted online was verified by means of luciferase and RNA pull-down assays. Furthermore, circ_001678 could sponge miR-326 to up-regulate ZEB1. On the other hand, the tumor-promoting effects of circ_001678 could be inhibited by anti-PD-L1/PD-1 treatment. Mechanistically, circ_001678 led to the activation of the PD-1/PD-L1 pathway to promote CD8+ T cell apoptosis, thereby inducing NSCLC cell immune escape via regulation of the miR-326/ZEB1 axis. To conclude, our findings revealed that circ_001678 sponges miR-326 to up-regulate ZEB1 expression and induce the PD-1/PD-L1 pathway-dependent immune escape, thereby promoting the malignant progression of NSCLC.

摘要

高通量环状 RNA(circRNA)测序鉴定出环状 RNA_001678(circ_001678)在非小细胞肺癌(NSCLC)组织中上调。因此,本研究旨在探讨 circRNA_001678 在 NSCLC 免疫逃逸中的功能和潜在机制。简而言之,采用商业购买的 NSCLC 细胞系进行体外实验,以评估 circ_001678 过表达或敲低对细胞生物学功能的影响,包括增殖、迁移和侵袭能力。此外,还评估了 circ_001678 对体内致瘤能力的影响以进行验证。结果表明,circ_001678 过表达增强了 NSCLC 的体外进展,并增强了体内致瘤能力。circ_001678 与 miR-326 的相互作用通过荧光素酶和 RNA 下拉实验进行了验证。此外,circ_001678 可以吸附 miR-326 来上调 ZEB1。另一方面,circ_001678 的促瘤作用可以通过抗 PD-L1/PD-1 治疗来抑制。机制上,circ_001678 导致 PD-1/PD-L1 通路激活,促进 CD8+T 细胞凋亡,从而通过调节 miR-326/ZEB1 轴诱导 NSCLC 细胞免疫逃逸。总之,我们的研究结果表明,circ_001678 通过吸附 miR-326 来上调 ZEB1 的表达,并诱导 PD-1/PD-L1 通路依赖性免疫逃逸,从而促进 NSCLC 的恶性进展。

相似文献

1
Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway.circ_001678/miRNA-326/ZEB1 轴通过调控 PD-1/PD-L1 通路对非小细胞肺癌的免疫调节作用。
Hum Mol Genet. 2022 Nov 28;31(23):4094-4106. doi: 10.1093/hmg/ddac155.
2
Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.环状RNA hsa_circ_0068252通过miR-1304-5p/PD-L1轴在非小细胞肺癌顺铂耐药和免疫反应中发挥作用。
Chemotherapy. 2022;67(4):223-233. doi: 10.1159/000525231. Epub 2022 Jun 1.
3
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).环状 RNA circ-CPA4/let-7 miRNA/PD-L1 轴调控非小细胞肺癌(NSCLC)中的细胞生长、干性、耐药性和免疫逃逸。
J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1.
4
Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.环状 RNA circ-TSPAN4 通过海绵吸附 miR-665 而上调 ZEB1 促进肺腺癌转移。
Mol Genet Genomic Med. 2019 Dec;7(12):e991. doi: 10.1002/mgg3.991. Epub 2019 Oct 1.
5
Circ_0000877 accelerates proliferation and immune escape of non-small cell lung cancer cells by regulating microRNA-637/E2F2 axis.环状 RNA 0000877 通过调控 microRNA-637/E2F2 轴促进非小细胞肺癌细胞的增殖和免疫逃逸。
Environ Toxicol. 2024 May;39(5):2980-2992. doi: 10.1002/tox.24172. Epub 2024 Feb 5.
6
Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.环状 RNA circ_0003028 通过 miR-1298-5p 调控 GOT2 促进非小细胞肺癌的发生。
Bioengineered. 2021 Dec;12(1):2326-2340. doi: 10.1080/21655979.2021.1935064.
7
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
8
Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.环状热休克蛋白 90A 通过调控 STAT3 信号和 PD-1/PD-L1 检查点促进非小细胞肺癌的细胞生长、干性和免疫逃逸。
Cancer Immunol Immunother. 2023 Jan;72(1):101-124. doi: 10.1007/s00262-022-03235-z. Epub 2022 Jun 24.
9
CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.环状 RNA VIM 沉默通过同时调控 miR-124/PD-L1 轴协同七氟醚抑制食管癌免疫逃逸和多种致癌活性。
Cell Biol Toxicol. 2022 Oct;38(5):825-845. doi: 10.1007/s10565-021-09613-0. Epub 2021 May 20.
10
Circular RNA hsa_circ_0004396 acts as a sponge of miR-615-5p to promote non-small cell lung cancer progression and radioresistance through the upregulation of P21-Activated Kinase 1.环状 RNA hsa_circ_0004396 通过上调 P21 激活激酶 1 作为 miR-615-5p 的海绵促进非小细胞肺癌的进展和放射抵抗。
J Clin Lab Anal. 2022 Jun;36(6):e24463. doi: 10.1002/jcla.24463. Epub 2022 May 2.

引用本文的文献

1
CircRNA in non‑small cell lung cancer: Potential biomarkers and therapeutic targets (Review).非小细胞肺癌中的环状RNA:潜在的生物标志物和治疗靶点(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13662. Epub 2025 Aug 29.
2
Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma.单细胞和空间转录组学揭示了RNA甲基化相关的miRNA风险模型与肝细胞癌免疫浸润之间的相关性。
Front Oncol. 2025 May 9;15:1553239. doi: 10.3389/fonc.2025.1553239. eCollection 2025.
3
miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1.
miR-128-3p通过靶向调控ZEB1降低急性髓系白血病的增殖和免疫逃逸
Appl Biochem Biotechnol. 2025 May 17. doi: 10.1007/s12010-025-05255-8.
4
Immunomodulatory behavior of CircRNAs in tumor microenvironment.环状RNA在肿瘤微环境中的免疫调节行为
Oncol Res. 2025 Apr 18;33(5):1105-1119. doi: 10.32604/or.2024.054623. eCollection 2025.
5
Non-coding RNAs as potential mediators of resistance to lung cancer immunotherapy and chemotherapy.非编码RNA作为肺癌免疫治疗和化疗耐药性的潜在介导因子。
Oncol Res. 2025 Apr 18;33(5):1033-1054. doi: 10.32604/or.2024.058256. eCollection 2025.
6
Hsa_circ_0000515 sequesters microRNA-296-5p and elevates RNF44 expression to encourage the NSCLC progression.人源环状RNA hsa_circ_0000515吸附微小RNA-296-5p并上调RNF44表达,从而促进非小细胞肺癌进展。
J Cell Commun Signal. 2025 Feb 24;19(1):e70005. doi: 10.1002/ccs3.70005. eCollection 2025 Mar.
7
Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review.非编码RNA在肺癌转移中的理论观点与临床应用:一项系统综述
Discov Oncol. 2025 Feb 12;16(1):169. doi: 10.1007/s12672-025-01919-3.
8
Circular RNAs: key players in tumor immune evasion.环状RNA:肿瘤免疫逃逸的关键参与者。
Mol Cell Biochem. 2025 Jun;480(6):3267-3295. doi: 10.1007/s11010-024-05186-8. Epub 2025 Jan 4.
9
Circular RNAs in lung cancer: implications for preventing therapeutic resistance.环状 RNA 与肺癌:在预防治疗抵抗中的作用。
EBioMedicine. 2024 Sep;107:105309. doi: 10.1016/j.ebiom.2024.105309. Epub 2024 Aug 26.
10
Circular RNAs in tumor immunity and immunotherapy.环状 RNA 在肿瘤免疫和免疫治疗中的作用。
Mol Cancer. 2024 Aug 21;23(1):171. doi: 10.1186/s12943-024-02082-z.